Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
|
Device | COBAS KRAS MUTATION TEST |
Generic Name | somatic gene mutation detection system |
Applicant |
Roche Molecular Systems, Inc. |
4300 hacienda drive |
pleasanton, CA 94588-2722 |
|
PMA Number | P140023 |
Supplement Number | S003 |
Date Received | 01/28/2016 |
Decision Date | 04/25/2016 |
Product Code |
OWD
|
Advisory Committee |
Pathology |
Supplement Type | real-time process |
Supplement Reason | change design/components/specifications/material |
Expedited Review Granted? | No |
Combination Product |
No
|
Approval Order Statement
Approval for the proposed formulation change (removal of anti-microbial agent ProClin 300) and process changes to production of KRAS reaction Mix, a component of cobas® KRAS Mutation Test. |
|
|